US Stock MarketDetailed Quotes

TENX Tenax Therapeutics

Watchlist
  • 4.1900
  • +0.1900+4.75%
Close Aug 16 16:00 ET
  • 4.0503
  • -0.1397-3.33%
Post 17:13 ET
14.28MMarket Cap-182P/E (TTM)

Tenax Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
197.05%3.67M
153.88%3.91M
-25.50%8.23M
30.78%3.34M
-27.42%2.12M
-56.81%1.24M
-43.37%1.54M
-66.23%11.05M
-20.46%2.55M
-23.27%2.92M
Selling and administrative expenses
29.49%1.34M
-3.22%1.23M
-11.81%5.01M
15.63%1.64M
-23.65%1.05M
-22.37%1.04M
-17.33%1.27M
-25.14%5.68M
-38.17%1.42M
-47.83%1.38M
-General and administrative expense
29.49%1.34M
-3.22%1.23M
-11.81%5.01M
15.63%1.64M
-23.65%1.05M
-22.37%1.04M
-17.33%1.27M
-25.14%5.68M
-38.17%1.42M
-47.83%1.38M
Research and development costs
1,076.15%2.33M
906.89%2.68M
-39.96%3.23M
49.74%1.7M
-30.80%1.07M
-87.02%197.9K
-77.44%265.74K
-78.62%5.38M
23.95%1.13M
32.51%1.54M
Operating profit
-197.05%-3.67M
-153.88%-3.91M
25.50%-8.23M
-30.78%-3.34M
27.42%-2.12M
56.81%-1.24M
43.37%-1.54M
66.23%-11.05M
20.46%-2.55M
23.27%-2.92M
Net non-operating interest income expense
-26.80%95.69K
-8.34%-7.96K
-439.43%-23.97K
-369.03K
39,187.10%145.4K
9,300.07%130.73K
-184.11%-7.35K
-368.18%-4.44K
0
-372
Non-operating interest income
-25.01%104.88K
----
----
----
--150.74K
221,898.41%139.86K
----
----
----
--0
Non-operating interest expense
0.69%9.19K
8.34%7.96K
439.43%23.97K
--2.15K
1,334.68%5.34K
514.96%9.13K
184.11%7.35K
368.18%4.44K
--0
--372
Other net income (expense)
171.79%654
-16.14%117.45K
5,854.03%547.24K
8,218.20%484.37K
-139.75%-911
45,279.03%140.06K
-96.39%9.19K
371.50%5.82K
-63.67%1.32K
Other non- operating income (expenses)
171.79%654
-16.14%117.45K
5,854.03%547.24K
8,218.20%484.37K
----
-139.75%-911
45,279.03%140.06K
-96.39%9.19K
371.50%5.82K
-63.67%1.32K
Income before tax
-223.20%-3.58M
-170.04%-3.8M
30.21%-7.71M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
65.98%-11.05M
20.61%-2.55M
23.22%-2.92M
Income tax
Net income
-223.20%-3.58M
-170.04%-3.8M
30.21%-7.71M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
65.98%-11.05M
20.61%-2.55M
23.22%-2.92M
Net income continuous Operations
-223.20%-3.58M
-170.04%-3.8M
30.21%-7.71M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
65.98%-11.05M
20.61%-2.55M
23.22%-2.92M
Minority interest income
Net income attributable to the parent company
-223.20%-3.58M
-170.04%-3.8M
30.21%-7.71M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
65.98%-11.05M
20.61%-2.55M
23.22%-2.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-223.20%-3.58M
-170.04%-3.8M
30.21%-7.71M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
65.98%-11.05M
20.61%-2.55M
23.22%-2.92M
Basic earnings per share
54.25%-1.83
74.21%-3.12
94.83%-31.04
82.97%-11.84
96.40%-6.4
97.80%-4
93.00%-12.1
76.21%-600.71
-14.33%-69.51
26.00%-177.6
Diluted earnings per share
54.25%-1.83
74.21%-3.12
94.83%-31.04
82.97%-11.84
96.40%-6.4
97.80%-4
93.00%-12.1
76.21%-600.71
-14.33%-69.51
26.00%-177.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 197.05%3.67M153.88%3.91M-25.50%8.23M30.78%3.34M-27.42%2.12M-56.81%1.24M-43.37%1.54M-66.23%11.05M-20.46%2.55M-23.27%2.92M
Selling and administrative expenses 29.49%1.34M-3.22%1.23M-11.81%5.01M15.63%1.64M-23.65%1.05M-22.37%1.04M-17.33%1.27M-25.14%5.68M-38.17%1.42M-47.83%1.38M
-General and administrative expense 29.49%1.34M-3.22%1.23M-11.81%5.01M15.63%1.64M-23.65%1.05M-22.37%1.04M-17.33%1.27M-25.14%5.68M-38.17%1.42M-47.83%1.38M
Research and development costs 1,076.15%2.33M906.89%2.68M-39.96%3.23M49.74%1.7M-30.80%1.07M-87.02%197.9K-77.44%265.74K-78.62%5.38M23.95%1.13M32.51%1.54M
Operating profit -197.05%-3.67M-153.88%-3.91M25.50%-8.23M-30.78%-3.34M27.42%-2.12M56.81%-1.24M43.37%-1.54M66.23%-11.05M20.46%-2.55M23.27%-2.92M
Net non-operating interest income expense -26.80%95.69K-8.34%-7.96K-439.43%-23.97K-369.03K39,187.10%145.4K9,300.07%130.73K-184.11%-7.35K-368.18%-4.44K0-372
Non-operating interest income -25.01%104.88K--------------150.74K221,898.41%139.86K--------------0
Non-operating interest expense 0.69%9.19K8.34%7.96K439.43%23.97K--2.15K1,334.68%5.34K514.96%9.13K184.11%7.35K368.18%4.44K--0--372
Other net income (expense) 171.79%654-16.14%117.45K5,854.03%547.24K8,218.20%484.37K-139.75%-91145,279.03%140.06K-96.39%9.19K371.50%5.82K-63.67%1.32K
Other non- operating income (expenses) 171.79%654-16.14%117.45K5,854.03%547.24K8,218.20%484.37K-----139.75%-91145,279.03%140.06K-96.39%9.19K371.50%5.82K-63.67%1.32K
Income before tax -223.20%-3.58M-170.04%-3.8M30.21%-7.71M-26.55%-3.23M32.39%-1.97M61.33%-1.11M48.31%-1.41M65.98%-11.05M20.61%-2.55M23.22%-2.92M
Income tax
Net income -223.20%-3.58M-170.04%-3.8M30.21%-7.71M-26.55%-3.23M32.39%-1.97M61.33%-1.11M48.31%-1.41M65.98%-11.05M20.61%-2.55M23.22%-2.92M
Net income continuous Operations -223.20%-3.58M-170.04%-3.8M30.21%-7.71M-26.55%-3.23M32.39%-1.97M61.33%-1.11M48.31%-1.41M65.98%-11.05M20.61%-2.55M23.22%-2.92M
Minority interest income
Net income attributable to the parent company -223.20%-3.58M-170.04%-3.8M30.21%-7.71M-26.55%-3.23M32.39%-1.97M61.33%-1.11M48.31%-1.41M65.98%-11.05M20.61%-2.55M23.22%-2.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -223.20%-3.58M-170.04%-3.8M30.21%-7.71M-26.55%-3.23M32.39%-1.97M61.33%-1.11M48.31%-1.41M65.98%-11.05M20.61%-2.55M23.22%-2.92M
Basic earnings per share 54.25%-1.8374.21%-3.1294.83%-31.0482.97%-11.8496.40%-6.497.80%-493.00%-12.176.21%-600.71-14.33%-69.5126.00%-177.6
Diluted earnings per share 54.25%-1.8374.21%-3.1294.83%-31.0482.97%-11.8496.40%-6.497.80%-493.00%-12.176.21%-600.71-14.33%-69.5126.00%-177.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg